Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR-Reference-Cited by-同舟云学术

Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR

Published:2021-06-14 Issue:3 Volume:107 Page:354-363
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Novitzky‐Basso Igor¹²^ORCID,Chen Carol¹,Chen Shiyi²³,Lipton Jeffrey H.¹²^ORCID,Kim Dennis D.¹²,Viswabandya Auro¹²,Kumar Rajat¹²,Lam Wilson¹²,Law Arjun¹²,Al‐Shaibani Zeyad¹²,Gerbitz Armin¹²,Pasic Ivan¹²^ORCID,Mattsson Jonas¹²,Michelis Fotios V.¹²^ORCID

Affiliation:

1. Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre Toronto ON Canada

2. University of Toronto Toronto ON Canada

3. Department of Biostatistics Princess Margaret Cancer Centre Toronto ON Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13673

Reference20 articles.

1. Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use